Healthcare provider profile · identity verified

Amit R Mehta, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology · CARY, NC · NPI 1740460377

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Amit R Mehta, M.D. received $807,540.54 in general payments during 2025 across 824 reported records.

PharmaEssentia USA Corporation accounted for 17.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 32 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jakafi.

Incyte Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JAKAFI as an associated drug or biological on 14854 records involving 6477 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Jakafi by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$807,540.54

824 reported records · 19 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
PharmaEssentia USA Corporation	Unresolved — no canonical attribution shown	$138,235.78	17.1%	114	2025
Incyte Corporation	Unresolved — no canonical attribution shown	$94,674.87	11.7%	135	2025
Astellas Pharma US Inc	Unresolved — no canonical attribution shown	$80,510.60	10.0%	50	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$79,258.62	9.8%	69	2025
GENZYME CORPORATION	Unresolved — no canonical attribution shown	$74,646.84	9.2%	46	2025
Janssen Biotech, Inc.	Unresolved — no canonical attribution shown	$72,799.51	9.0%	112	2025
Geron Corporation	Unresolved — no canonical attribution shown	$62,723.94	7.8%	58	2025
EMD Serono, Inc.	Unresolved — no canonical attribution shown	$44,201.86	5.5%	32	2025
Aveo Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$39,091.50	4.8%	32	2025
Rigel Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$34,926.98	4.3%	49	2025
Pharming Healthcare, Inc.	Unresolved — no canonical attribution shown	$27,071.12	3.4%	44	2025
RECORDATI_RARE_DISEASES_INC.	Unresolved — no canonical attribution shown	$18,860.10	2.3%	19	2025
Merck Sharp & Dohme LLC	Unresolved — no canonical attribution shown	$17,760.26	2.2%	13	2025
Novartis Pharmaceuticals Corporation	Unresolved — no canonical attribution shown	$15,064.82	1.9%	16	2025
Syndax Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$5,546.11	0.7%	6	2025
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$1,865.57	0.2%	26	2025
Exelixis Inc.	Unresolved — no canonical attribution shown	$175.00	0.0%	1	2025
Janssen Scientific Affairs, LLC	Unresolved — no canonical attribution shown	$92.74	0.0%	1	2025
Adaptive Biotechnologies Corporation	Unresolved — no canonical attribution shown	$34.32	0.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$555,917.82	138
Travel and Lodging	$127,322.68	400
Consulting Fee	$93,958.75	24
Honoraria	$15,312.19	5
Food and Beverage	$15,029.10	257

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
BESREMI Normalized: besremi	Drug	PharmaEssentia USA Corporation	$138,235.78	114	2025
Source payment records 2025-01-16 · PharmaEssentia USA Corporation · $2,010.00 · Open Payments source 2025-02-20 · PharmaEssentia USA Corporation · $621.01 · Open Payments source 2025-02-20 · PharmaEssentia USA Corporation · $329.63 · Open Payments source 2025-02-20 · PharmaEssentia USA Corporation · $125.00 · Open Payments source 2025-03-05 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-03-05 · PharmaEssentia USA Corporation · $40.00 · Open Payments source 2025-03-05 · PharmaEssentia USA Corporation · $18.89 · Open Payments source 2025-03-05 · PharmaEssentia USA Corporation · $15.35 · Open Payments source 2025-03-05 · PharmaEssentia USA Corporation · $14.00 · Open Payments source 2025-03-12 · PharmaEssentia USA Corporation · $1,675.00 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $207.20 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $366.37 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $1,279.64 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $100.31 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $16,080.00 · Open Payments source 2025-03-18 · PharmaEssentia USA Corporation · $1,062.48 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $1.62 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $14.00 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $20.00 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $24.03 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $33.50 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $64.00 · Open Payments source 2025-04-09 · PharmaEssentia USA Corporation · $6,700.00 · Open Payments source 2025-04-24 · PharmaEssentia USA Corporation · $341.21 · Open Payments source 2025-04-24 · PharmaEssentia USA Corporation · $562.37 · Open Payments source 2025-04-24 · PharmaEssentia USA Corporation · $1,200.00 · Open Payments source 2025-04-24 · PharmaEssentia USA Corporation · $124.91 · Open Payments source 2025-04-28 · PharmaEssentia USA Corporation · $6,700.00 · Open Payments source 2025-04-30 · PharmaEssentia USA Corporation · $14.05 · Open Payments source 2025-04-30 · PharmaEssentia USA Corporation · $21.35 · Open Payments source 2025-04-30 · PharmaEssentia USA Corporation · $33.48 · Open Payments source 2025-05-05 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-05-12 · PharmaEssentia USA Corporation · $311.90 · Open Payments source 2025-05-12 · PharmaEssentia USA Corporation · $358.28 · Open Payments source 2025-05-12 · PharmaEssentia USA Corporation · $440.25 · Open Payments source 2025-05-12 · PharmaEssentia USA Corporation · $104.58 · Open Payments source 2025-05-19 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $9.95 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $11.20 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $11.99 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $15.26 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $32.00 · Open Payments source 2025-05-21 · PharmaEssentia USA Corporation · $54.79 · Open Payments source 2025-06-01 · PharmaEssentia USA Corporation · $83.15 · Open Payments source 2025-06-03 · PharmaEssentia USA Corporation · $761.28 · Open Payments source 2025-06-03 · PharmaEssentia USA Corporation · $101.60 · Open Payments source 2025-06-09 · PharmaEssentia USA Corporation · $4,690.00 · Open Payments source 2025-06-17 · PharmaEssentia USA Corporation · $1,131.43 · Open Payments source 2025-06-17 · PharmaEssentia USA Corporation · $115.79 · Open Payments source 2025-06-25 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-06-25 · PharmaEssentia USA Corporation · $11.75 · Open Payments source 2025-07-19 · PharmaEssentia USA Corporation · $406.97 · Open Payments source 2025-08-06 · PharmaEssentia USA Corporation · $995.53 · Open Payments source 2025-08-06 · PharmaEssentia USA Corporation · $100.00 · Open Payments source 2025-08-13 · PharmaEssentia USA Corporation · $4,690.00 · Open Payments source 2025-08-14 · PharmaEssentia USA Corporation · $208.63 · Open Payments source 2025-08-14 · PharmaEssentia USA Corporation · $557.25 · Open Payments source 2025-08-14 · PharmaEssentia USA Corporation · $121.82 · Open Payments source 2025-08-20 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-08-25 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $1.62 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $14.00 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $24.76 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $61.00 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $64.00 · Open Payments source 2025-08-27 · PharmaEssentia USA Corporation · $125.88 · Open Payments source 2025-09-10 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $0.81 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $13.57 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $14.00 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $20.00 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $48.00 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $86.43 · Open Payments source 2025-09-17 · PharmaEssentia USA Corporation · $145.49 · Open Payments source 2025-09-18 · PharmaEssentia USA Corporation · $332.56 · Open Payments source 2025-09-18 · PharmaEssentia USA Corporation · $802.21 · Open Payments source 2025-09-22 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-09-24 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-09-29 · PharmaEssentia USA Corporation · $65.63 · Open Payments source 2025-09-29 · PharmaEssentia USA Corporation · $363.95 · Open Payments source 2025-09-29 · PharmaEssentia USA Corporation · $261.95 · Open Payments source 2025-10-06 · PharmaEssentia USA Corporation · $6,700.00 · Open Payments source 2025-10-06 · PharmaEssentia USA Corporation · $18.34 · Open Payments source 2025-10-06 · PharmaEssentia USA Corporation · $36.95 · Open Payments source 2025-10-06 · PharmaEssentia USA Corporation · $62.97 · Open Payments source 2025-10-23 · PharmaEssentia USA Corporation · $125.00 · Open Payments source 2025-10-27 · PharmaEssentia USA Corporation · $116.22 · Open Payments source 2025-10-27 · PharmaEssentia USA Corporation · $593.12 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $3,350.00 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $5,360.00 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $22.00 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $37.86 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $45.48 · Open Payments source 2025-10-29 · PharmaEssentia USA Corporation · $74.10 · Open Payments source 2025-11-10 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-11-10 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-11-18 · PharmaEssentia USA Corporation · $369.55 · Open Payments source 2025-11-18 · PharmaEssentia USA Corporation · $6,700.00 · Open Payments source 2025-11-18 · PharmaEssentia USA Corporation · $109.66 · Open Payments source 2025-11-24 · PharmaEssentia USA Corporation · $4.52 · Open Payments source 2025-11-24 · PharmaEssentia USA Corporation · $89.60 · Open Payments source 2025-11-26 · PharmaEssentia USA Corporation · $1,340.00 · Open Payments source 2025-12-03 · PharmaEssentia USA Corporation · $1,039.86 · Open Payments source 2025-12-10 · PharmaEssentia USA Corporation · $4,690.00 · Open Payments source 2025-12-11 · PharmaEssentia USA Corporation · $121.08 · Open Payments source 2025-12-11 · PharmaEssentia USA Corporation · $146.43 · Open Payments source 2025-12-11 · PharmaEssentia USA Corporation · $589.36 · Open Payments source 2025-12-15 · PharmaEssentia USA Corporation · $6,700.00 · Open Payments source 2025-12-15 · PharmaEssentia USA Corporation · $418.75 · Open Payments source 2025-12-17 · PharmaEssentia USA Corporation · $244.25 · Open Payments source 2025-12-17 · PharmaEssentia USA Corporation · $334.19 · Open Payments source 2025-12-17 · PharmaEssentia USA Corporation · $934.15 · Open Payments source 2025-12-18 · PharmaEssentia USA Corporation · $91.68 · Open Payments source
XTANDI Normalized: xtandi	Drug	Astellas Pharma US Inc, PFIZER INC.	$96,293.06	78	2025
Source payment records 2025-01-16 · PFIZER INC. · $88.05 · Open Payments source 2025-01-21 · PFIZER INC. · $6.63 · Open Payments source 2025-01-22 · PFIZER INC. · $5,050.00 · Open Payments source 2025-01-25 · PFIZER INC. · $1,263.50 · Open Payments source 2025-02-10 · PFIZER INC. · $15.61 · Open Payments source 2025-03-22 · Astellas Pharma US Inc · $226.92 · Open Payments source 2025-03-22 · Astellas Pharma US Inc · $21.00 · Open Payments source 2025-03-22 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-03-22 · Astellas Pharma US Inc · $476.94 · Open Payments source 2025-03-25 · PFIZER INC. · $40.60 · Open Payments source 2025-03-31 · PFIZER INC. · $7.03 · Open Payments source 2025-04-04 · PFIZER INC. · $5,050.00 · Open Payments source 2025-04-08 · PFIZER INC. · $119.72 · Open Payments source 2025-04-10 · PFIZER INC. · $5,050.00 · Open Payments source 2025-04-11 · PFIZER INC. · $1,137.15 · Open Payments source 2025-04-15 · PFIZER INC. · $5.67 · Open Payments source 2025-04-15 · PFIZER INC. · $12.46 · Open Payments source 2025-04-16 · PFIZER INC. · $42.04 · Open Payments source 2025-04-22 · PFIZER INC. · $388.56 · Open Payments source 2025-04-24 · PFIZER INC. · $1,545.32 · Open Payments source 2025-04-26 · Astellas Pharma US Inc · $33.59 · Open Payments source 2025-04-26 · Astellas Pharma US Inc · $320.37 · Open Payments source 2025-04-26 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-04-26 · Astellas Pharma US Inc · $12.44 · Open Payments source 2025-04-26 · Astellas Pharma US Inc · $109.39 · Open Payments source 2025-04-29 · PFIZER INC. · $60.10 · Open Payments source 2025-05-01 · PFIZER INC. · $5,425.00 · Open Payments source 2025-05-01 · Astellas Pharma US Inc · $752.56 · Open Payments source 2025-05-01 · Astellas Pharma US Inc · $134.99 · Open Payments source 2025-05-01 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-05-03 · PFIZER INC. · $593.60 · Open Payments source 2025-05-05 · PFIZER INC. · $9.95 · Open Payments source 2025-05-05 · PFIZER INC. · $51.20 · Open Payments source 2025-05-05 · PFIZER INC. · $58.57 · Open Payments source 2025-05-07 · PFIZER INC. · $158.82 · Open Payments source 2025-05-07 · PFIZER INC. · $723.36 · Open Payments source 2025-05-07 · PFIZER INC. · $176.82 · Open Payments source 2025-05-08 · Astellas Pharma US Inc · $905.61 · Open Payments source 2025-05-08 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-05-08 · Astellas Pharma US Inc · $124.46 · Open Payments source 2025-05-21 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-05-21 · Astellas Pharma US Inc · $803.58 · Open Payments source 2025-05-21 · Astellas Pharma US Inc · $130.00 · Open Payments source 2025-05-22 · PFIZER INC. · $121.29 · Open Payments source 2025-05-28 · PFIZER INC. · $5,050.00 · Open Payments source 2025-06-10 · PFIZER INC. · $146.30 · Open Payments source 2025-06-10 · PFIZER INC. · $177.05 · Open Payments source 2025-06-10 · PFIZER INC. · $568.58 · Open Payments source 2025-06-16 · PFIZER INC. · $1.62 · Open Payments source 2025-06-16 · PFIZER INC. · $64.00 · Open Payments source 2025-06-16 · PFIZER INC. · $44.34 · Open Payments source 2025-06-16 · PFIZER INC. · $136.88 · Open Payments source 2025-06-16 · PFIZER INC. · $14.00 · Open Payments source 2025-06-19 · PFIZER INC. · $93.17 · Open Payments source 2025-06-24 · PFIZER INC. · $5,050.00 · Open Payments source 2025-06-27 · PFIZER INC. · $1,315.16 · Open Payments source 2025-08-08 · PFIZER INC. · $3.90 · Open Payments source 2025-08-08 · PFIZER INC. · $2.14 · Open Payments source 2025-08-14 · PFIZER INC. · $603.73 · Open Payments source 2025-08-21 · PFIZER INC. · $116.38 · Open Payments source 2025-08-23 · PFIZER INC. · $319.06 · Open Payments source 2025-08-27 · PFIZER INC. · $30.66 · Open Payments source 2025-08-27 · PFIZER INC. · $32.00 · Open Payments source 2025-08-27 · PFIZER INC. · $14.00 · Open Payments source 2025-08-27 · PFIZER INC. · $1.62 · Open Payments source 2025-08-28 · PFIZER INC. · $5,050.00 · Open Payments source 2025-09-04 · PFIZER INC. · $772.18 · Open Payments source 2025-10-21 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-10-21 · Astellas Pharma US Inc · $78.72 · Open Payments source 2025-10-21 · Astellas Pharma US Inc · $697.56 · Open Payments source 2025-11-10 · PFIZER INC. · $106.10 · Open Payments source 2025-11-14 · PFIZER INC. · $5,050.00 · Open Payments source 2025-11-14 · Astellas Pharma US Inc · $547.30 · Open Payments source 2025-11-14 · Astellas Pharma US Inc · $6,020.00 · Open Payments source 2025-11-14 · Astellas Pharma US Inc · $27.84 · Open Payments source 2025-11-14 · Astellas Pharma US Inc · $544.80 · Open Payments source 2025-11-18 · PFIZER INC. · $1,389.85 · Open Payments source 2025-11-18 · PFIZER INC. · $11.22 · Open Payments source
MONJUVI Normalized: monjuvi	Drug	Incyte Corporation	$86,631.76	120	2025
Source payment records 2025-03-11 · Incyte Corporation · $52.10 · Open Payments source 2025-03-11 · Incyte Corporation · $177.42 · Open Payments source 2025-03-11 · Incyte Corporation · $11.40 · Open Payments source 2025-03-11 · Incyte Corporation · $14.06 · Open Payments source 2025-03-11 · Incyte Corporation · $635.72 · Open Payments source 2025-03-11 · Incyte Corporation · $263.18 · Open Payments source 2025-03-11 · Incyte Corporation · $123.48 · Open Payments source 2025-03-11 · Incyte Corporation · $20.00 · Open Payments source 2025-03-12 · Incyte Corporation · $23.78 · Open Payments source 2025-03-18 · Incyte Corporation · $5,500.00 · Open Payments source 2025-03-26 · Incyte Corporation · $19.80 · Open Payments source 2025-03-26 · Incyte Corporation · $246.75 · Open Payments source 2025-03-26 · Incyte Corporation · $572.47 · Open Payments source 2025-03-26 · Incyte Corporation · $90.85 · Open Payments source 2025-03-26 · Incyte Corporation · $308.18 · Open Payments source 2025-03-26 · Incyte Corporation · $97.28 · Open Payments source 2025-03-26 · Incyte Corporation · $6.12 · Open Payments source 2025-03-27 · Incyte Corporation · $12.28 · Open Payments source 2025-04-01 · Incyte Corporation · $4,400.00 · Open Payments source 2025-04-07 · Incyte Corporation · $275.00 · Open Payments source 2025-04-30 · Incyte Corporation · $441.72 · Open Payments source 2025-05-13 · Incyte Corporation · $10.39 · Open Payments source 2025-05-13 · Incyte Corporation · $54.68 · Open Payments source 2025-05-13 · Incyte Corporation · $244.34 · Open Payments source 2025-05-13 · Incyte Corporation · $526.97 · Open Payments source 2025-05-13 · Incyte Corporation · $11.20 · Open Payments source 2025-05-13 · Incyte Corporation · $572.47 · Open Payments source 2025-05-13 · Incyte Corporation · $7.61 · Open Payments source 2025-05-13 · Incyte Corporation · $32.00 · Open Payments source 2025-05-14 · Incyte Corporation · $16.62 · Open Payments source 2025-05-20 · Incyte Corporation · $4,400.00 · Open Payments source 2025-06-27 · Incyte Corporation · $26.92 · Open Payments source 2025-06-27 · Incyte Corporation · $139.99 · Open Payments source 2025-06-28 · Incyte Corporation · $29.98 · Open Payments source 2025-06-28 · Incyte Corporation · $29.98 · Open Payments source 2025-06-28 · Incyte Corporation · $20.00 · Open Payments source 2025-06-28 · Incyte Corporation · $1.62 · Open Payments source 2025-06-28 · Incyte Corporation · $569.96 · Open Payments source 2025-06-28 · Incyte Corporation · $59.98 · Open Payments source 2025-06-28 · Incyte Corporation · $64.00 · Open Payments source 2025-06-28 · Incyte Corporation · $10.39 · Open Payments source 2025-06-28 · Incyte Corporation · $62.49 · Open Payments source 2025-06-28 · Incyte Corporation · $14.00 · Open Payments source 2025-06-28 · Incyte Corporation · $303.97 · Open Payments source 2025-07-17 · Incyte Corporation · $5,225.00 · Open Payments source 2025-07-22 · Incyte Corporation · $47.47 · Open Payments source 2025-07-22 · Incyte Corporation · $321.40 · Open Payments source 2025-07-22 · Incyte Corporation · $11.67 · Open Payments source 2025-07-22 · Incyte Corporation · $20.00 · Open Payments source 2025-07-22 · Incyte Corporation · $376.26 · Open Payments source 2025-07-22 · Incyte Corporation · $578.47 · Open Payments source 2025-07-22 · Incyte Corporation · $54.50 · Open Payments source 2025-07-23 · Incyte Corporation · $145.20 · Open Payments source 2025-07-23 · Incyte Corporation · $117.20 · Open Payments source 2025-07-23 · Incyte Corporation · $298.19 · Open Payments source 2025-07-23 · Incyte Corporation · $457.98 · Open Payments source 2025-07-23 · Incyte Corporation · $16.89 · Open Payments source 2025-07-24 · Incyte Corporation · $4.02 · Open Payments source 2025-07-24 · Incyte Corporation · $12.66 · Open Payments source 2025-08-05 · Incyte Corporation · $5,500.00 · Open Payments source 2025-08-07 · Incyte Corporation · $5.64 · Open Payments source 2025-08-12 · Incyte Corporation · $5,500.00 · Open Payments source 2025-08-19 · Incyte Corporation · $1,650.00 · Open Payments source 2025-08-28 · Incyte Corporation · $891.37 · Open Payments source 2025-09-17 · Incyte Corporation · $180.00 · Open Payments source 2025-09-17 · Incyte Corporation · $124.99 · Open Payments source 2025-09-17 · Incyte Corporation · $16.08 · Open Payments source 2025-09-17 · Incyte Corporation · $3.37 · Open Payments source 2025-09-17 · Incyte Corporation · $46.39 · Open Payments source 2025-09-17 · Incyte Corporation · $692.96 · Open Payments source 2025-09-17 · Incyte Corporation · $332.55 · Open Payments source 2025-09-17 · Incyte Corporation · $195.38 · Open Payments source 2025-09-18 · Incyte Corporation · $9.25 · Open Payments source 2025-09-22 · Incyte Corporation · $22.40 · Open Payments source 2025-09-22 · Incyte Corporation · $99.52 · Open Payments source 2025-09-24 · Incyte Corporation · $4,400.00 · Open Payments source 2025-09-24 · Incyte Corporation · $2,200.00 · Open Payments source 2025-09-30 · Incyte Corporation · $703.17 · Open Payments source 2025-09-30 · Incyte Corporation · $63.63 · Open Payments source 2025-09-30 · Incyte Corporation · $18.53 · Open Payments source 2025-09-30 · Incyte Corporation · $6.37 · Open Payments source 2025-09-30 · Incyte Corporation · $51.00 · Open Payments source 2025-09-30 · Incyte Corporation · $148.53 · Open Payments source 2025-09-30 · Incyte Corporation · $457.98 · Open Payments source 2025-09-30 · Incyte Corporation · $124.17 · Open Payments source 2025-09-30 · Incyte Corporation · $154.04 · Open Payments source 2025-10-07 · Incyte Corporation · $5,500.00 · Open Payments source 2025-10-24 · Incyte Corporation · $10.00 · Open Payments source 2025-10-24 · Incyte Corporation · $57.00 · Open Payments source 2025-10-24 · Incyte Corporation · $16.56 · Open Payments source 2025-10-24 · Incyte Corporation · $870.48 · Open Payments source 2025-10-24 · Incyte Corporation · $63.00 · Open Payments source 2025-11-12 · Incyte Corporation · $686.96 · Open Payments source 2025-11-12 · Incyte Corporation · $124.81 · Open Payments source 2025-11-12 · Incyte Corporation · $472.67 · Open Payments source 2025-11-12 · Incyte Corporation · $23.74 · Open Payments source 2025-11-12 · Incyte Corporation · $282.00 · Open Payments source 2025-11-12 · Incyte Corporation · $46.60 · Open Payments source 2025-11-13 · Incyte Corporation · $10.69 · Open Payments source 2025-11-13 · Incyte Corporation · $19.89 · Open Payments source 2025-11-13 · Incyte Corporation · $7.29 · Open Payments source 2025-11-13 · Incyte Corporation · $277.48 · Open Payments source 2025-11-13 · Incyte Corporation · $168.94 · Open Payments source 2025-11-13 · Incyte Corporation · $807.45 · Open Payments source 2025-11-13 · Incyte Corporation · $124.99 · Open Payments source 2025-11-19 · Incyte Corporation · $1,650.00 · Open Payments source 2025-12-02 · Incyte Corporation · $21.76 · Open Payments source 2025-12-02 · Incyte Corporation · $641.72 · Open Payments source 2025-12-02 · Incyte Corporation · $201.70 · Open Payments source 2025-12-02 · Incyte Corporation · $1.62 · Open Payments source 2025-12-02 · Incyte Corporation · $55.30 · Open Payments source 2025-12-02 · Incyte Corporation · $70.00 · Open Payments source 2025-12-03 · Incyte Corporation · $5,500.00 · Open Payments source 2025-12-03 · Incyte Corporation · $5,500.00 · Open Payments source 2025-12-03 · Incyte Corporation · $5,500.00 · Open Payments source 2025-12-03 · Incyte Corporation · $56.00 · Open Payments source 2025-12-03 · Incyte Corporation · $14.01 · Open Payments source 2025-12-03 · Incyte Corporation · $13.72 · Open Payments source 2025-12-19 · Incyte Corporation · $1,650.00 · Open Payments source 2025-12-19 · Incyte Corporation · $4,400.00 · Open Payments source
CARVYKTI Normalized: carvykti	Drug	Janssen Biotech, Inc.	$68,272.96	96	2025
Source payment records 2025-02-03 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-02-18 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $419.73 · Open Payments source 2025-02-26 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-03-12 · Janssen Biotech, Inc. · $2,775.00 · Open Payments source 2025-03-12 · Janssen Biotech, Inc. · $107.56 · Open Payments source 2025-03-13 · Janssen Biotech, Inc. · $247.50 · Open Payments source 2025-03-13 · Janssen Biotech, Inc. · $1,165.50 · Open Payments source 2025-03-14 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-03-21 · Janssen Biotech, Inc. · $3,607.50 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $117.60 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $17.41 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $116.10 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $20.72 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $10.82 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $33.11 · Open Payments source 2025-03-30 · Janssen Biotech, Inc. · $1,127.67 · Open Payments source 2025-04-01 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-04-04 · Janssen Biotech, Inc. · $9.70 · Open Payments source 2025-04-28 · Janssen Biotech, Inc. · $592.84 · Open Payments source 2025-04-28 · Janssen Biotech, Inc. · $55.00 · Open Payments source 2025-04-29 · Janssen Biotech, Inc. · $494.27 · Open Payments source 2025-05-15 · Janssen Biotech, Inc. · $533.86 · Open Payments source 2025-05-20 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-05-20 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-05-22 · Janssen Biotech, Inc. · $555.00 · Open Payments source 2025-06-05 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-06-11 · Janssen Biotech, Inc. · $229.03 · Open Payments source 2025-06-14 · Janssen Biotech, Inc. · $151.22 · Open Payments source 2025-06-16 · Janssen Biotech, Inc. · $530.42 · Open Payments source 2025-06-17 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-06-25 · Janssen Biotech, Inc. · $125.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $1.62 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $48.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $677.93 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $190.25 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $25.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $16.58 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $121.79 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $15.26 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $14.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $64.00 · Open Payments source 2025-06-27 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-06-30 · Janssen Biotech, Inc. · $1,196.85 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $25.00 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $7.14 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $46.31 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $20.00 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $23.60 · Open Payments source 2025-07-07 · Janssen Biotech, Inc. · $331.70 · Open Payments source 2025-07-07 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-07-15 · Janssen Biotech, Inc. · $75.19 · Open Payments source 2025-07-16 · Janssen Biotech, Inc. · $224.35 · Open Payments source 2025-07-18 · Janssen Biotech, Inc. · $554.63 · Open Payments source 2025-07-23 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $657.59 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $149.86 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $19.36 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $36.89 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $20.57 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $132.97 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $945.62 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $139.95 · Open Payments source 2025-07-29 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-08-06 · Janssen Biotech, Inc. · $575.78 · Open Payments source 2025-08-11 · Janssen Biotech, Inc. · $49.50 · Open Payments source 2025-08-12 · Janssen Biotech, Inc. · $117.30 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $37.18 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $12.66 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $32.74 · Open Payments source 2025-09-03 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-09-04 · Janssen Biotech, Inc. · $80.35 · Open Payments source 2025-09-05 · Janssen Biotech, Inc. · $144.15 · Open Payments source 2025-09-05 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-09-08 · Janssen Biotech, Inc. · $794.44 · Open Payments source 2025-09-12 · Janssen Biotech, Inc. · $632.27 · Open Payments source 2025-09-12 · Janssen Biotech, Inc. · $279.02 · Open Payments source 2025-09-15 · Janssen Biotech, Inc. · $156.02 · Open Payments source 2025-09-15 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $31.12 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $20.40 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $17.51 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $17.92 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $16.08 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $52.60 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $29.92 · Open Payments source 2025-10-10 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-11-12 · Janssen Biotech, Inc. · $19.50 · Open Payments source 2025-11-13 · Janssen Biotech, Inc. · $50.00 · Open Payments source 2025-11-19 · Janssen Biotech, Inc. · $555.00 · Open Payments source 2025-12-04 · Janssen Biotech, Inc. · $146.19 · Open Payments source 2025-12-05 · Janssen Biotech, Inc. · $577.24 · Open Payments source 2025-12-08 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source
RYBREVANT Normalized: rybrevant	Drug	Janssen Biotech, Inc.	$68,272.96	96	2025
Source payment records 2025-02-03 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-02-18 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $419.73 · Open Payments source 2025-02-26 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-03-12 · Janssen Biotech, Inc. · $2,775.00 · Open Payments source 2025-03-12 · Janssen Biotech, Inc. · $107.56 · Open Payments source 2025-03-13 · Janssen Biotech, Inc. · $247.50 · Open Payments source 2025-03-13 · Janssen Biotech, Inc. · $1,165.50 · Open Payments source 2025-03-14 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-03-21 · Janssen Biotech, Inc. · $3,607.50 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $117.60 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $17.41 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $116.10 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $20.72 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $10.82 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $33.11 · Open Payments source 2025-03-30 · Janssen Biotech, Inc. · $1,127.67 · Open Payments source 2025-04-01 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-04-04 · Janssen Biotech, Inc. · $9.70 · Open Payments source 2025-04-28 · Janssen Biotech, Inc. · $592.84 · Open Payments source 2025-04-28 · Janssen Biotech, Inc. · $55.00 · Open Payments source 2025-04-29 · Janssen Biotech, Inc. · $494.27 · Open Payments source 2025-05-15 · Janssen Biotech, Inc. · $533.86 · Open Payments source 2025-05-20 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-05-20 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-05-22 · Janssen Biotech, Inc. · $555.00 · Open Payments source 2025-06-05 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-06-11 · Janssen Biotech, Inc. · $229.03 · Open Payments source 2025-06-14 · Janssen Biotech, Inc. · $151.22 · Open Payments source 2025-06-16 · Janssen Biotech, Inc. · $530.42 · Open Payments source 2025-06-17 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-06-25 · Janssen Biotech, Inc. · $125.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $1.62 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $48.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $677.93 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $190.25 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $25.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $16.58 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $121.79 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $15.26 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $14.00 · Open Payments source 2025-06-26 · Janssen Biotech, Inc. · $64.00 · Open Payments source 2025-06-27 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-06-30 · Janssen Biotech, Inc. · $1,196.85 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $25.00 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $7.14 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $46.31 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $20.00 · Open Payments source 2025-07-02 · Janssen Biotech, Inc. · $23.60 · Open Payments source 2025-07-07 · Janssen Biotech, Inc. · $331.70 · Open Payments source 2025-07-07 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-07-15 · Janssen Biotech, Inc. · $75.19 · Open Payments source 2025-07-16 · Janssen Biotech, Inc. · $224.35 · Open Payments source 2025-07-18 · Janssen Biotech, Inc. · $554.63 · Open Payments source 2025-07-23 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $657.59 · Open Payments source 2025-07-24 · Janssen Biotech, Inc. · $149.86 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $19.36 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $36.89 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $20.57 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $132.97 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $945.62 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $139.95 · Open Payments source 2025-07-29 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-08-06 · Janssen Biotech, Inc. · $575.78 · Open Payments source 2025-08-11 · Janssen Biotech, Inc. · $49.50 · Open Payments source 2025-08-12 · Janssen Biotech, Inc. · $117.30 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $37.18 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $12.66 · Open Payments source 2025-08-20 · Janssen Biotech, Inc. · $32.74 · Open Payments source 2025-09-03 · Janssen Biotech, Inc. · $5.50 · Open Payments source 2025-09-04 · Janssen Biotech, Inc. · $80.35 · Open Payments source 2025-09-05 · Janssen Biotech, Inc. · $144.15 · Open Payments source 2025-09-05 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-09-08 · Janssen Biotech, Inc. · $794.44 · Open Payments source 2025-09-12 · Janssen Biotech, Inc. · $632.27 · Open Payments source 2025-09-12 · Janssen Biotech, Inc. · $279.02 · Open Payments source 2025-09-15 · Janssen Biotech, Inc. · $156.02 · Open Payments source 2025-09-15 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $31.12 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $20.40 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $17.51 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $17.92 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $16.08 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $52.60 · Open Payments source 2025-09-19 · Janssen Biotech, Inc. · $29.92 · Open Payments source 2025-10-10 · Janssen Biotech, Inc. · $1,110.00 · Open Payments source 2025-11-12 · Janssen Biotech, Inc. · $19.50 · Open Payments source 2025-11-13 · Janssen Biotech, Inc. · $50.00 · Open Payments source 2025-11-19 · Janssen Biotech, Inc. · $555.00 · Open Payments source 2025-12-04 · Janssen Biotech, Inc. · $146.19 · Open Payments source 2025-12-05 · Janssen Biotech, Inc. · $577.24 · Open Payments source 2025-12-08 · Janssen Biotech, Inc. · $4,162.50 · Open Payments source
PADCEV Normalized: padcev	Biological, Drug	Astellas Pharma US Inc, PFIZER INC.	$57,362.42	38	2025
Source payment records 2025-02-27 · Astellas Pharma US Inc · $446.37 · Open Payments source 2025-02-27 · Astellas Pharma US Inc · $118.54 · Open Payments source 2025-02-27 · Astellas Pharma US Inc · $6,020.00 · Open Payments source 2025-02-27 · Astellas Pharma US Inc · $765.24 · Open Payments source 2025-02-27 · Astellas Pharma US Inc · $486.31 · Open Payments source 2025-03-14 · Astellas Pharma US Inc · $18.30 · Open Payments source 2025-03-14 · Astellas Pharma US Inc · $329.34 · Open Payments source 2025-03-14 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-03-14 · Astellas Pharma US Inc · $548.11 · Open Payments source 2025-03-14 · Astellas Pharma US Inc · $9.78 · Open Payments source 2025-03-22 · PFIZER INC. · $100.30 · Open Payments source 2025-07-03 · Astellas Pharma US Inc · $1,290.00 · Open Payments source 2025-07-17 · Astellas Pharma US Inc · $110.09 · Open Payments source 2025-07-17 · Astellas Pharma US Inc · $7.05 · Open Payments source 2025-07-17 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-07-17 · Astellas Pharma US Inc · $1,105.65 · Open Payments source 2025-09-16 · Astellas Pharma US Inc · $15.91 · Open Payments source 2025-10-01 · PFIZER INC. · $96.07 · Open Payments source 2025-10-02 · PFIZER INC. · $124.74 · Open Payments source 2025-10-06 · PFIZER INC. · $5,050.00 · Open Payments source 2025-10-07 · PFIZER INC. · $12.46 · Open Payments source 2025-10-07 · PFIZER INC. · $5.11 · Open Payments source 2025-10-09 · PFIZER INC. · $5,050.00 · Open Payments source 2025-10-09 · Astellas Pharma US Inc · $6,020.00 · Open Payments source 2025-10-09 · Astellas Pharma US Inc · $631.57 · Open Payments source 2025-10-09 · Astellas Pharma US Inc · $365.18 · Open Payments source 2025-10-09 · Astellas Pharma US Inc · $108.98 · Open Payments source 2025-10-09 · Astellas Pharma US Inc · $335.29 · Open Payments source 2025-10-11 · PFIZER INC. · $1,413.80 · Open Payments source 2025-10-14 · PFIZER INC. · $1,479.56 · Open Payments source 2025-10-15 · PFIZER INC. · $75.84 · Open Payments source 2025-10-16 · Astellas Pharma US Inc · $114.17 · Open Payments source 2025-10-16 · Astellas Pharma US Inc · $1,156.65 · Open Payments source 2025-10-16 · Astellas Pharma US Inc · $5,160.00 · Open Payments source 2025-10-20 · PFIZER INC. · $5,050.00 · Open Payments source 2025-10-21 · PFIZER INC. · $6.85 · Open Payments source 2025-10-24 · PFIZER INC. · $1,315.16 · Open Payments source 2025-11-20 · Astellas Pharma US Inc · $2,100.00 · Open Payments source
RYTELO Normalized: rytelo	Drug	Geron Corporation	$55,550.69	49	2025
Source payment records 2025-01-17 · Geron Corporation · $2,560.00 · Open Payments source 2025-04-09 · Geron Corporation · $1,280.00 · Open Payments source 2025-04-17 · Geron Corporation · $124.25 · Open Payments source 2025-04-17 · Geron Corporation · $1,749.00 · Open Payments source 2025-04-30 · Geron Corporation · $4,160.00 · Open Payments source 2025-04-30 · Geron Corporation · $12.46 · Open Payments source 2025-05-06 · Geron Corporation · $96.94 · Open Payments source 2025-05-06 · Geron Corporation · $2,385.00 · Open Payments source 2025-06-11 · Geron Corporation · $4,160.00 · Open Payments source 2025-06-11 · Geron Corporation · $20.42 · Open Payments source 2025-06-11 · Geron Corporation · $1,280.00 · Open Payments source 2025-06-11 · Geron Corporation · $1,280.00 · Open Payments source 2025-06-25 · Geron Corporation · $1,280.00 · Open Payments source 2025-07-07 · Geron Corporation · $2,560.00 · Open Payments source 2025-08-08 · Geron Corporation · $35.00 · Open Payments source 2025-08-14 · Geron Corporation · $945.98 · Open Payments source 2025-08-20 · Geron Corporation · $61.47 · Open Payments source 2025-09-03 · Geron Corporation · $87.39 · Open Payments source 2025-09-04 · Geron Corporation · $636.00 · Open Payments source 2025-09-04 · Geron Corporation · $703.89 · Open Payments source 2025-09-04 · Geron Corporation · $340.24 · Open Payments source 2025-09-24 · Geron Corporation · $3,360.00 · Open Payments source 2025-09-26 · Geron Corporation · $335.28 · Open Payments source 2025-09-26 · Geron Corporation · $1,157.15 · Open Payments source 2025-09-26 · Geron Corporation · $3,173.50 · Open Payments source 2025-09-27 · Geron Corporation · $60.05 · Open Payments source 2025-10-08 · Geron Corporation · $7,360.00 · Open Payments source 2025-10-08 · Geron Corporation · $10.02 · Open Payments source 2025-10-08 · Geron Corporation · $19.37 · Open Payments source 2025-10-08 · Geron Corporation · $17.51 · Open Payments source 2025-10-08 · Geron Corporation · $21.00 · Open Payments source 2025-10-08 · Geron Corporation · $1.27 · Open Payments source 2025-10-14 · Geron Corporation · $466.37 · Open Payments source 2025-10-22 · Geron Corporation · $7,360.00 · Open Payments source 2025-11-05 · Geron Corporation · $15.04 · Open Payments source 2025-11-05 · Geron Corporation · $30.00 · Open Payments source 2025-11-05 · Geron Corporation · $32.00 · Open Payments source 2025-11-05 · Geron Corporation · $41.50 · Open Payments source 2025-11-05 · Geron Corporation · $10.00 · Open Payments source 2025-11-06 · Geron Corporation · $66.43 · Open Payments source 2025-11-06 · Geron Corporation · $20.94 · Open Payments source 2025-11-06 · Geron Corporation · $39.81 · Open Payments source 2025-11-06 · Geron Corporation · $173.05 · Open Payments source 2025-12-04 · Geron Corporation · $31.29 · Open Payments source 2025-12-04 · Geron Corporation · $44.68 · Open Payments source 2025-12-04 · Geron Corporation · $20.00 · Open Payments source 2025-12-05 · Geron Corporation · $145.92 · Open Payments source 2025-12-06 · Geron Corporation · $20.47 · Open Payments source 2025-12-11 · Geron Corporation · $5,760.00 · Open Payments source
WAYRILZ Normalized: wayrilz	Drug	GENZYME CORPORATION	$47,381.70	29	2025
Source payment records 2025-02-28 · GENZYME CORPORATION · $1,294.00 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $8,088.00 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $311.22 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $565.96 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $615.05 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $26.64 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $13.00 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $32.00 · Open Payments source 2025-04-10 · GENZYME CORPORATION · $34.03 · Open Payments source 2025-06-16 · GENZYME CORPORATION · $2,265.00 · Open Payments source 2025-06-16 · GENZYME CORPORATION · $1,294.00 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $4,836.00 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $692.22 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $627.15 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $560.37 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $364.63 · Open Payments source 2025-07-24 · GENZYME CORPORATION · $111.27 · Open Payments source 2025-09-13 · GENZYME CORPORATION · $5,176.00 · Open Payments source 2025-09-15 · GENZYME CORPORATION · $88.98 · Open Payments source 2025-09-15 · GENZYME CORPORATION · $60.06 · Open Payments source 2025-09-15 · GENZYME CORPORATION · $94.90 · Open Payments source 2025-09-15 · GENZYME CORPORATION · $7,728.00 · Open Payments source 2025-10-30 · GENZYME CORPORATION · $2,265.00 · Open Payments source 2025-11-05 · GENZYME CORPORATION · $2,265.00 · Open Payments source 2025-11-06 · GENZYME CORPORATION · $110.18 · Open Payments source 2025-11-06 · GENZYME CORPORATION · $6,794.00 · Open Payments source 2025-11-06 · GENZYME CORPORATION · $984.20 · Open Payments source 2025-11-06 · GENZYME CORPORATION · $7.06 · Open Payments source 2025-12-05 · GENZYME CORPORATION · $77.78 · Open Payments source
TALZENNA Normalized: talzenna	Drug	PFIZER INC.	$46,357.93	41	2025
Source payment records 2025-02-10 · PFIZER INC. · $15.61 · Open Payments source 2025-03-25 · PFIZER INC. · $40.60 · Open Payments source 2025-03-31 · PFIZER INC. · $7.03 · Open Payments source 2025-04-04 · PFIZER INC. · $5,050.00 · Open Payments source 2025-04-07 · PFIZER INC. · $4,625.00 · Open Payments source 2025-04-08 · PFIZER INC. · $119.72 · Open Payments source 2025-04-10 · PFIZER INC. · $5,050.00 · Open Payments source 2025-04-11 · PFIZER INC. · $1,137.15 · Open Payments source 2025-04-15 · PFIZER INC. · $5.67 · Open Payments source 2025-04-15 · PFIZER INC. · $12.46 · Open Payments source 2025-04-16 · PFIZER INC. · $42.04 · Open Payments source 2025-04-24 · PFIZER INC. · $1,545.32 · Open Payments source 2025-04-29 · PFIZER INC. · $60.10 · Open Payments source 2025-05-01 · PFIZER INC. · $5,425.00 · Open Payments source 2025-05-03 · PFIZER INC. · $593.60 · Open Payments source 2025-05-05 · PFIZER INC. · $9.95 · Open Payments source 2025-05-05 · PFIZER INC. · $51.20 · Open Payments source 2025-05-05 · PFIZER INC. · $58.57 · Open Payments source 2025-05-07 · PFIZER INC. · $158.82 · Open Payments source 2025-05-07 · PFIZER INC. · $723.36 · Open Payments source 2025-05-07 · PFIZER INC. · $176.82 · Open Payments source 2025-06-09 · PFIZER INC. · $700.00 · Open Payments source 2025-06-11 · PFIZER INC. · $788.74 · Open Payments source 2025-06-19 · PFIZER INC. · $93.17 · Open Payments source 2025-06-24 · PFIZER INC. · $5,050.00 · Open Payments source 2025-06-27 · PFIZER INC. · $1,315.16 · Open Payments source 2025-08-08 · PFIZER INC. · $3.90 · Open Payments source 2025-08-08 · PFIZER INC. · $2.14 · Open Payments source 2025-08-14 · PFIZER INC. · $603.73 · Open Payments source 2025-08-21 · PFIZER INC. · $116.38 · Open Payments source 2025-08-23 · PFIZER INC. · $319.06 · Open Payments source 2025-08-27 · PFIZER INC. · $30.66 · Open Payments source 2025-08-27 · PFIZER INC. · $32.00 · Open Payments source 2025-08-27 · PFIZER INC. · $14.00 · Open Payments source 2025-08-27 · PFIZER INC. · $1.62 · Open Payments source 2025-08-28 · PFIZER INC. · $5,050.00 · Open Payments source 2025-09-04 · PFIZER INC. · $772.18 · Open Payments source 2025-11-10 · PFIZER INC. · $106.10 · Open Payments source 2025-11-14 · PFIZER INC. · $5,050.00 · Open Payments source 2025-11-18 · PFIZER INC. · $1,389.85 · Open Payments source 2025-11-18 · PFIZER INC. · $11.22 · Open Payments source
FOTIVDA Normalized: fotivda	Drug	Aveo Pharmaceuticals, Inc.	$39,091.50	32	2025
Source payment records 2025-01-17 · Aveo Pharmaceuticals, Inc. · $605.00 · Open Payments source 2025-02-13 · Aveo Pharmaceuticals, Inc. · $1,513.00 · Open Payments source 2025-02-13 · Aveo Pharmaceuticals, Inc. · $1,513.00 · Open Payments source 2025-02-22 · Aveo Pharmaceuticals, Inc. · $422.66 · Open Payments source 2025-03-05 · Aveo Pharmaceuticals, Inc. · $5,445.00 · Open Payments source 2025-03-12 · Aveo Pharmaceuticals, Inc. · $14.00 · Open Payments source 2025-03-12 · Aveo Pharmaceuticals, Inc. · $102.09 · Open Payments source 2025-04-14 · Aveo Pharmaceuticals, Inc. · $22.35 · Open Payments source 2025-04-14 · Aveo Pharmaceuticals, Inc. · $1,543.24 · Open Payments source 2025-04-25 · Aveo Pharmaceuticals, Inc. · $228.48 · Open Payments source 2025-04-25 · Aveo Pharmaceuticals, Inc. · $316.37 · Open Payments source 2025-04-30 · Aveo Pharmaceuticals, Inc. · $26.48 · Open Payments source 2025-04-30 · Aveo Pharmaceuticals, Inc. · $3,630.00 · Open Payments source 2025-05-15 · Aveo Pharmaceuticals, Inc. · $54.57 · Open Payments source 2025-05-15 · Aveo Pharmaceuticals, Inc. · $5,445.00 · Open Payments source 2025-07-14 · Aveo Pharmaceuticals, Inc. · $446.37 · Open Payments source 2025-07-14 · Aveo Pharmaceuticals, Inc. · $295.58 · Open Payments source 2025-07-18 · Aveo Pharmaceuticals, Inc. · $169.49 · Open Payments source 2025-07-18 · Aveo Pharmaceuticals, Inc. · $360.47 · Open Payments source 2025-07-30 · Aveo Pharmaceuticals, Inc. · $5,445.00 · Open Payments source 2025-07-30 · Aveo Pharmaceuticals, Inc. · $5,445.00 · Open Payments source 2025-08-13 · Aveo Pharmaceuticals, Inc. · $118.83 · Open Payments source 2025-08-13 · Aveo Pharmaceuticals, Inc. · $128.60 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $0.81 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $20.00 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $115.08 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $22.60 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $104.75 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $48.00 · Open Payments source 2025-08-20 · Aveo Pharmaceuticals, Inc. · $14.00 · Open Payments source 2025-09-14 · Aveo Pharmaceuticals, Inc. · $30.68 · Open Payments source 2025-10-21 · Aveo Pharmaceuticals, Inc. · $5,445.00 · Open Payments source
TAVALISSE Normalized: tavalisse	Drug	Rigel Pharmaceuticals, Inc.	$34,926.98	49	2025
Source payment records 2025-04-25 · Rigel Pharmaceuticals, Inc. · $62.95 · Open Payments source 2025-06-06 · Rigel Pharmaceuticals, Inc. · $326.96 · Open Payments source 2025-06-06 · Rigel Pharmaceuticals, Inc. · $566.37 · Open Payments source 2025-06-06 · Rigel Pharmaceuticals, Inc. · $48.60 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $82.40 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $39.70 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $64.00 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $1.62 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $13.30 · Open Payments source 2025-06-20 · Rigel Pharmaceuticals, Inc. · $5,148.00 · Open Payments source 2025-07-16 · Rigel Pharmaceuticals, Inc. · $122.64 · Open Payments source 2025-07-16 · Rigel Pharmaceuticals, Inc. · $1,128.00 · Open Payments source 2025-07-16 · Rigel Pharmaceuticals, Inc. · $275.72 · Open Payments source 2025-07-16 · Rigel Pharmaceuticals, Inc. · $432.16 · Open Payments source 2025-07-31 · Rigel Pharmaceuticals, Inc. · $5,148.00 · Open Payments source 2025-08-07 · Rigel Pharmaceuticals, Inc. · $35.92 · Open Payments source 2025-08-07 · Rigel Pharmaceuticals, Inc. · $12.00 · Open Payments source 2025-08-07 · Rigel Pharmaceuticals, Inc. · $27.08 · Open Payments source 2025-09-02 · Rigel Pharmaceuticals, Inc. · $126.37 · Open Payments source 2025-09-02 · Rigel Pharmaceuticals, Inc. · $306.96 · Open Payments source 2025-09-02 · Rigel Pharmaceuticals, Inc. · $179.67 · Open Payments source 2025-09-11 · Rigel Pharmaceuticals, Inc. · $5,148.00 · Open Payments source 2025-09-18 · Rigel Pharmaceuticals, Inc. · $185.57 · Open Payments source 2025-09-18 · Rigel Pharmaceuticals, Inc. · $20.00 · Open Payments source 2025-09-18 · Rigel Pharmaceuticals, Inc. · $22.15 · Open Payments source 2025-09-25 · Rigel Pharmaceuticals, Inc. · $168.49 · Open Payments source 2025-09-25 · Rigel Pharmaceuticals, Inc. · $551.45 · Open Payments source 2025-09-25 · Rigel Pharmaceuticals, Inc. · $52.41 · Open Payments source 2025-10-04 · Rigel Pharmaceuticals, Inc. · $276.97 · Open Payments source 2025-10-04 · Rigel Pharmaceuticals, Inc. · $1,033.50 · Open Payments source 2025-10-08 · Rigel Pharmaceuticals, Inc. · $5,148.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $14.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $0.81 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $32.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $75.58 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $173.96 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $14.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $5,148.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $11.00 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $33.62 · Open Payments source 2025-10-20 · Rigel Pharmaceuticals, Inc. · $67.00 · Open Payments source 2025-10-28 · Rigel Pharmaceuticals, Inc. · $402.36 · Open Payments source 2025-10-29 · Rigel Pharmaceuticals, Inc. · $70.49 · Open Payments source 2025-11-25 · Rigel Pharmaceuticals, Inc. · $12.00 · Open Payments source 2025-11-25 · Rigel Pharmaceuticals, Inc. · $179.53 · Open Payments source 2025-11-25 · Rigel Pharmaceuticals, Inc. · $74.27 · Open Payments source 2025-11-25 · Rigel Pharmaceuticals, Inc. · $6.58 · Open Payments source 2025-11-25 · Rigel Pharmaceuticals, Inc. · $101.82 · Open Payments source 2025-12-05 · Rigel Pharmaceuticals, Inc. · $1,755.00 · Open Payments source
SARCLISA Normalized: sarclisa	Biological	GENZYME CORPORATION	$19,494.07	11	2025
Source payment records 2025-04-22 · GENZYME CORPORATION · $5,500.00 · Open Payments source 2025-04-22 · GENZYME CORPORATION · $662.62 · Open Payments source 2025-04-23 · GENZYME CORPORATION · $28.57 · Open Payments source 2025-04-23 · GENZYME CORPORATION · $65.50 · Open Payments source 2025-05-15 · GENZYME CORPORATION · $123.74 · Open Payments source 2025-05-15 · GENZYME CORPORATION · $6,794.00 · Open Payments source 2025-05-15 · GENZYME CORPORATION · $6.06 · Open Payments source 2025-08-07 · GENZYME CORPORATION · $96.16 · Open Payments source 2025-08-07 · GENZYME CORPORATION · $5,500.00 · Open Payments source 2025-08-07 · GENZYME CORPORATION · $710.17 · Open Payments source 2025-10-08 · GENZYME CORPORATION · $7.25 · Open Payments source
SYLVANT Normalized: sylvant	Drug	RECORDATI_RARE_DISEASES_INC.	$18,860.10	19	2025
Source payment records 2025-01-07 · RECORDATI_RARE_DISEASES_INC. · $619.65 · Open Payments source 2025-01-09 · RECORDATI_RARE_DISEASES_INC. · $500.00 · Open Payments source 2025-01-15 · RECORDATI_RARE_DISEASES_INC. · $202.17 · Open Payments source 2025-01-15 · RECORDATI_RARE_DISEASES_INC. · $5,250.00 · Open Payments source 2025-01-15 · RECORDATI_RARE_DISEASES_INC. · $37.46 · Open Payments source 2025-01-15 · RECORDATI_RARE_DISEASES_INC. · $563.95 · Open Payments source 2025-01-15 · RECORDATI_RARE_DISEASES_INC. · $187.09 · Open Payments source 2025-01-16 · RECORDATI_RARE_DISEASES_INC. · $334.48 · Open Payments source 2025-01-21 · RECORDATI_RARE_DISEASES_INC. · $125.99 · Open Payments source 2025-01-28 · RECORDATI_RARE_DISEASES_INC. · $4,750.00 · Open Payments source 2025-01-28 · RECORDATI_RARE_DISEASES_INC. · $37.99 · Open Payments source 2025-01-28 · RECORDATI_RARE_DISEASES_INC. · $381.67 · Open Payments source 2025-01-28 · RECORDATI_RARE_DISEASES_INC. · $221.23 · Open Payments source 2025-02-25 · RECORDATI_RARE_DISEASES_INC. · $223.88 · Open Payments source 2025-03-24 · RECORDATI_RARE_DISEASES_INC. · $4,750.00 · Open Payments source 2025-03-24 · RECORDATI_RARE_DISEASES_INC. · $28.38 · Open Payments source 2025-03-24 · RECORDATI_RARE_DISEASES_INC. · $446.97 · Open Payments source 2025-03-24 · RECORDATI_RARE_DISEASES_INC. · $137.00 · Open Payments source 2025-04-30 · RECORDATI_RARE_DISEASES_INC. · $62.19 · Open Payments source
KEYTRUDA Normalized: keytruda	Biological	Merck Sharp & Dohme LLC	$17,746.05	12	2025
Source payment records 2025-02-18 · Merck Sharp & Dohme LLC · $1,499.90 · Open Payments source 2025-02-18 · Merck Sharp & Dohme LLC · $56.65 · Open Payments source 2025-03-05 · Merck Sharp & Dohme LLC · $4,270.00 · Open Payments source 2025-03-05 · Merck Sharp & Dohme LLC · $150.00 · Open Payments source 2025-03-06 · Merck Sharp & Dohme LLC · $1,431.16 · Open Payments source 2025-03-06 · Merck Sharp & Dohme LLC · $74.24 · Open Payments source 2025-03-12 · Merck Sharp & Dohme LLC · $150.00 · Open Payments source 2025-03-12 · Merck Sharp & Dohme LLC · $4,270.00 · Open Payments source 2025-05-14 · Merck Sharp & Dohme LLC · $1,312.42 · Open Payments source 2025-05-14 · Merck Sharp & Dohme LLC · $111.68 · Open Payments source 2025-05-30 · Merck Sharp & Dohme LLC · $4,270.00 · Open Payments source 2025-06-04 · Merck Sharp & Dohme LLC · $150.00 · Open Payments source
Jakafi Normalized: jakafi	Drug	Incyte Corporation	$14,864.25	25	2025
Source payment records 2025-03-11 · Incyte Corporation · $52.10 · Open Payments source 2025-03-11 · Incyte Corporation · $177.42 · Open Payments source 2025-03-11 · Incyte Corporation · $11.40 · Open Payments source 2025-03-11 · Incyte Corporation · $14.06 · Open Payments source 2025-03-11 · Incyte Corporation · $635.72 · Open Payments source 2025-03-11 · Incyte Corporation · $263.18 · Open Payments source 2025-03-11 · Incyte Corporation · $123.48 · Open Payments source 2025-03-11 · Incyte Corporation · $20.00 · Open Payments source 2025-03-12 · Incyte Corporation · $23.78 · Open Payments source 2025-03-18 · Incyte Corporation · $5,500.00 · Open Payments source 2025-06-12 · Incyte Corporation · $1,650.00 · Open Payments source 2025-08-01 · Incyte Corporation · $39.43 · Open Payments source 2025-08-02 · Incyte Corporation · $16.10 · Open Payments source 2025-08-02 · Incyte Corporation · $11.84 · Open Payments source 2025-08-02 · Incyte Corporation · $194.46 · Open Payments source 2025-08-02 · Incyte Corporation · $4.16 · Open Payments source 2025-08-02 · Incyte Corporation · $32.00 · Open Payments source 2025-08-02 · Incyte Corporation · $14.00 · Open Payments source 2025-08-02 · Incyte Corporation · $234.98 · Open Payments source 2025-08-02 · Incyte Corporation · $166.36 · Open Payments source 2025-08-02 · Incyte Corporation · $228.98 · Open Payments source 2025-08-02 · Incyte Corporation · $224.99 · Open Payments source 2025-08-02 · Incyte Corporation · $0.81 · Open Payments source 2025-08-19 · Incyte Corporation · $4,400.00 · Open Payments source 2025-11-20 · Incyte Corporation · $825.00 · Open Payments source
PLUVICTO Normalized: pluvicto	Drug	Novartis Pharmaceuticals Corporation	$12,264.82	14	2025
Source payment records 2025-07-11 · Novartis Pharmaceuticals Corporation · $351.73 · Open Payments source 2025-07-11 · Novartis Pharmaceuticals Corporation · $315.08 · Open Payments source 2025-07-11 · Novartis Pharmaceuticals Corporation · $236.56 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $92.28 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $161.07 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $9,000.00 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $486.02 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $13.16 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $64.00 · Open Payments source 2025-07-12 · Novartis Pharmaceuticals Corporation · $2.17 · Open Payments source 2025-10-22 · Novartis Pharmaceuticals Corporation · $700.00 · Open Payments source 2025-11-18 · Novartis Pharmaceuticals Corporation · $119.52 · Open Payments source 2025-11-18 · Novartis Pharmaceuticals Corporation · $337.85 · Open Payments source 2025-11-18 · Novartis Pharmaceuticals Corporation · $385.38 · Open Payments source
IMETELSTAT Normalized: imetelstat	Drug	Geron Corporation	$7,173.25	9	2025
Source payment records 2025-09-03 · Geron Corporation · $84.85 · Open Payments source 2025-09-03 · Geron Corporation · $42.23 · Open Payments source 2025-10-22 · Geron Corporation · $2,240.00 · Open Payments source 2025-10-25 · Geron Corporation · $276.79 · Open Payments source 2025-10-25 · Geron Corporation · $54.00 · Open Payments source 2025-10-25 · Geron Corporation · $22.00 · Open Payments source 2025-10-25 · Geron Corporation · $18.40 · Open Payments source 2025-10-28 · Geron Corporation · $3,840.00 · Open Payments source 2025-10-28 · Geron Corporation · $594.98 · Open Payments source
REVUFORJ Normalized: revuforj	Drug	Syndax Pharmaceuticals, Inc.	$5,546.11	6	2025
Source payment records 2025-09-20 · Syndax Pharmaceuticals, Inc. · $50.88 · Open Payments source 2025-09-20 · Syndax Pharmaceuticals, Inc. · $53.04 · Open Payments source 2025-09-20 · Syndax Pharmaceuticals, Inc. · $5,212.50 · Open Payments source 2025-09-20 · Syndax Pharmaceuticals, Inc. · $8.62 · Open Payments source 2025-09-20 · Syndax Pharmaceuticals, Inc. · $219.80 · Open Payments source 2025-09-20 · Syndax Pharmaceuticals, Inc. · $1.27 · Open Payments source
ERLEADA Normalized: erleada	Drug	Janssen Biotech, Inc., Janssen Scientific Affairs, LLC	$4,619.29	17	2025
Source payment records 2025-02-13 · Janssen Biotech, Inc. · $77.87 · Open Payments source 2025-02-20 · Janssen Biotech, Inc. · $32.00 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $746.66 · Open Payments source 2025-03-04 · Janssen Biotech, Inc. · $8.11 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $0.81 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $11.48 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $150.30 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $14.07 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $47.91 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $32.00 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $53.79 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $140.30 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-03-14 · Janssen Biotech, Inc. · $2,497.50 · Open Payments source 2025-04-04 · Janssen Biotech, Inc. · $693.75 · Open Payments source 2025-04-28 · Janssen Scientific Affairs, LLC · $92.74 · Open Payments source
AKEEGA Normalized: akeega	Drug	Janssen Biotech, Inc., Janssen Scientific Affairs, LLC	$4,611.18	16	2025
Source payment records 2025-02-13 · Janssen Biotech, Inc. · $77.87 · Open Payments source 2025-02-20 · Janssen Biotech, Inc. · $32.00 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $746.66 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $0.81 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $11.48 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $150.30 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $14.07 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $47.91 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $32.00 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $53.79 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $140.30 · Open Payments source 2025-03-05 · Janssen Biotech, Inc. · $10.00 · Open Payments source 2025-03-14 · Janssen Biotech, Inc. · $2,497.50 · Open Payments source 2025-04-04 · Janssen Biotech, Inc. · $693.75 · Open Payments source 2025-04-28 · Janssen Scientific Affairs, LLC · $92.74 · Open Payments source
JOENJA Normalized: joenja	Drug	Pharming Healthcare, Inc.	$2,800.00	2	2025
Source payment records 2025-03-24 · Pharming Healthcare, Inc. · $400.00 · Open Payments source 2025-10-22 · Pharming Healthcare, Inc. · $2,400.00 · Open Payments source
PIPELINE Normalized: pipeline	Device	Medtronic, Inc.	$1,530.68	20	2025
Source payment records 2025-08-25 · Medtronic, Inc. · $188.48 · Open Payments source 2025-08-25 · Medtronic, Inc. · $4.68 · Open Payments source 2025-08-25 · Medtronic, Inc. · $194.83 · Open Payments source 2025-08-25 · Medtronic, Inc. · $4.68 · Open Payments source 2025-09-24 · Medtronic, Inc. · $69.54 · Open Payments source 2025-09-24 · Medtronic, Inc. · $19.72 · Open Payments source 2025-09-24 · Medtronic, Inc. · $19.72 · Open Payments source 2025-09-24 · Medtronic, Inc. · $139.00 · Open Payments source 2025-09-24 · Medtronic, Inc. · $75.29 · Open Payments source 2025-09-25 · Medtronic, Inc. · $72.90 · Open Payments source 2025-09-25 · Medtronic, Inc. · $57.15 · Open Payments source 2025-09-25 · Medtronic, Inc. · $15.49 · Open Payments source 2025-09-25 · Medtronic, Inc. · $19.72 · Open Payments source 2025-09-25 · Medtronic, Inc. · $139.00 · Open Payments source 2025-09-25 · Medtronic, Inc. · $75.29 · Open Payments source 2025-09-26 · Medtronic, Inc. · $163.39 · Open Payments source 2025-09-26 · Medtronic, Inc. · $15.49 · Open Payments source 2025-09-26 · Medtronic, Inc. · $10.56 · Open Payments source 2025-09-26 · Medtronic, Inc. · $15.49 · Open Payments source 2025-11-19 · Medtronic, Inc. · $230.26 · Open Payments source
RUCONEST Normalized: ruconest	Biological	Pharming Healthcare, Inc.	$270.45	3	2025
Source payment records 2025-02-11 · Pharming Healthcare, Inc. · $99.12 · Open Payments source 2025-04-02 · Pharming Healthcare, Inc. · $87.70 · Open Payments source 2025-10-14 · Pharming Healthcare, Inc. · $83.63 · Open Payments source
MO.MA ULTRA Normalized: mo ma ultra	Device	Medtronic, Inc.	$224.82	5	2025
Source payment records 2025-07-13 · Medtronic, Inc. · $0.80 · Open Payments source 2025-07-13 · Medtronic, Inc. · $148.50 · Open Payments source 2025-07-14 · Medtronic, Inc. · $28.68 · Open Payments source 2025-07-14 · Medtronic, Inc. · $19.68 · Open Payments source 2025-07-15 · Medtronic, Inc. · $27.16 · Open Payments source
CABOMETYX Normalized: cabometyx	Drug	Exelixis Inc.	$175.00	1	2025
Source payment records 2025-05-31 · Exelixis Inc. · $175.00 · Open Payments source
CABLIVI Normalized: cablivi	Biological	GENZYME CORPORATION	$158.94	2	2025
Source payment records 2025-06-21 · GENZYME CORPORATION · $81.16 · Open Payments source 2025-12-05 · GENZYME CORPORATION · $77.78 · Open Payments source
ABRE Normalized: abre	Device	Medtronic, Inc.	$110.07	1	2025
Source payment records 2025-07-10 · Medtronic, Inc. · $110.07 · Open Payments source
Gavreto Normalized: gavreto	Drug	Rigel Pharmaceuticals, Inc.	$62.95	1	2025
Source payment records 2025-04-25 · Rigel Pharmaceuticals, Inc. · $62.95 · Open Payments source
Rezlidhia Normalized: rezlidhia	Drug	Rigel Pharmaceuticals, Inc.	$62.95	1	2025
Source payment records 2025-04-25 · Rigel Pharmaceuticals, Inc. · $62.95 · Open Payments source
clonoSEQ Normalized: clonoseq	Device	Adaptive Biotechnologies Corporation	$34.32	1	2025
Source payment records 2025-04-03 · Adaptive Biotechnologies Corporation · $34.32 · Open Payments source
ORGOVYX Normalized: orgovyx	Drug	PFIZER INC.	$21.65	3	2025
Source payment records 2025-02-10 · PFIZER INC. · $15.61 · Open Payments source 2025-08-08 · PFIZER INC. · $3.90 · Open Payments source 2025-08-08 · PFIZER INC. · $2.14 · Open Payments source
LYNPARZA Normalized: lynparza	Biological	Merck Sharp & Dohme LLC	$14.21	1	2025
Source payment records 2025-10-03 · Merck Sharp & Dohme LLC · $14.21 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Jakafi jakafi	2025	Jakafi	2024	14 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Incyte Corporation Exact reporting entity; no affiliate inference	2025	JAKAFI open payments reported associated product	CMS Open Payments — General Payments 14854 supporting records · 6477 recipient NPIs · example record 1225959940	Jakafi · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydroxyurea	Hydroxyurea	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Jakafi	Ruxolitinib Phosphate	14	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$807,540.54 · 824 records	PharmaEssentia USA Corporation	ABRE, AKEEGA, BESREMI, CABLIVI, CABOMETYX, CARVYKTI, ERLEADA, FOTIVDA, Gavreto, IMETELSTAT, JOENJA, Jakafi, KEYTRUDA, LYNPARZA, MO.MA ULTRA, MONJUVI, ORGOVYX, PADCEV, PIPELINE, PLUVICTO, REVUFORJ, RUCONEST, RYBREVANT, RYTELO, Rezlidhia, SARCLISA, SYLVANT, TALZENNA, TAVALISSE, WAYRILZ, XTANDI, clonoSEQ	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jakafi play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Incyte Corporation?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error